Reserpine: no changes advised for now.
D000818:Animals; D004353:Drug Evaluation, Preclinical; D006801:Humans; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced; D051381:Rats; D012110:Reserpine / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D012110:Reserpine